Table 15.
Enteral Feeding Intervention | Effect on Pathophysiological Mechanism (Compared to Placebo/No Intervention) |
---|---|
Carbohydrate or sugar-based interventions | |
(SC) GOS + (LC) FOS | % Gastric slow wave propagation (electrogastrography) ↑ [243] Gastric half emptying time (echography) ↓ [243] Intestinal transit time (passage carmine red) ↑ [244] Stool pH ↓ [244] Stool viscosity ↑ [244] |
SC GOS + LC FOS + AOS | Fecal IL8 = [245] Fecal calprotectin = [245] |
Protein or amino acid-based interventions | |
Lactoferrin | Whole blood CD4+ CD25high Foxp3+ Treg cell number ↑ [246] |
L-Glutamine | Lactulose recovery in urine day 7 ↓ [247] Lactulose recovery in urine day 30 ↓ [247] Lactulose/mannitol recovery ratio in urine day 7 ↓ [247] Lactulose/mannitol recovery ratio in urine day 30 ↓ [247] |
Probiotic interventions | |
Lactobacillus reuteri | % Gastric slow wave propagation (electrogastrography) ↑ [243] Gastric half emptying time (echography) ↓ [243] |
Bifidobacterium lactis | Lactulose/mannitol recovery ratio in urine day 30 ↓ [248] |
Other interventions | |
Mixture of probiotics, prebiotics and lactoferrin | Serum IL5 (protein) at 0, 14 and 28 days = [249] Serum IL10 (protein) at 0, 14 and 28 days (protein) = [249] Serum IL17 (protein) at 0, 14 and 28 days = [249] Serum IFNϒ (protein) 0, 14 days = [249] Serum IFNϒ (protein) 28 days ↑ [249] |
↑ depicts an increase, ↓ depicts a decrease; SC-GOS, short chain galacto-oligosaccharides; LC-FOS, long chain fructo-oligosaccharides.